litlas
ログインアカウント作成

Jean Bergeron

1973–2025 年に発表

90
論文数
18,057
被引用数
75
h 指数
87
i10 指数

被引用数

Jean Bergeron の年別被引用数1975 年: 被引用 1 件1976 年: 被引用 7 件1977 年: 被引用 2 件1978 年: 被引用 5 件1979 年: 被引用 5 件1980 年: 被引用 3 件1981 年: 被引用 6 件1982 年: 被引用 5 件1983 年: 被引用 3 件1984 年: 被引用 1 件1985 年: 被引用 6 件1987 年: 被引用 3 件1988 年: 被引用 6 件1989 年: 被引用 7 件1990 年: 被引用 5 件1991 年: 被引用 4 件1992 年: 被引用 9 件1993 年: 被引用 6 件1994 年: 被引用 13 件1995 年: 被引用 22 件1996 年: 被引用 17 件1997 年: 被引用 36 件1998 年: 被引用 41 件1999 年: 被引用 31 件2000 年: 被引用 41 件2001 年: 被引用 79 件2002 年: 被引用 76 件2003 年: 被引用 93 件2004 年: 被引用 108 件2005 年: 被引用 118 件2006 年: 被引用 126 件2007 年: 被引用 146 件2008 年: 被引用 121 件2009 年: 被引用 131 件2010 年: 被引用 119 件2011 年: 被引用 139 件2012 年: 被引用 122 件2013 年: 被引用 119 件2014 年: 被引用 113 件2015 年: 被引用 140 件2016 年: 被引用 186 件2017 年: 被引用 177 件2018 年: 被引用 131 件2019 年: 被引用 443 件2020 年: 被引用 427 件2021 年: 被引用 435 件2022 年: 被引用 357 件2023 年: 被引用 277 件2024 年: 被引用 445 件2025 年: 被引用 228 件2026 年: 被引用 15 件1986 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,817 件、この内訳の 24.6%カナダ: 引用元論文 609 件、この内訳の 8.3%イギリス: 引用元論文 482 件、この内訳の 6.5%中国: 引用元論文 387 件、この内訳の 5.3%イタリア: 引用元論文 358 件、この内訳の 4.9%ドイツ: 引用元論文 289 件、この内訳の 3.9%オーストラリア: 引用元論文 275 件、この内訳の 3.7%オランダ: 引用元論文 267 件、この内訳の 3.6%フランス: 引用元論文 247 件、この内訳の 3.4%スペイン: 引用元論文 178 件、この内訳の 2.4%日本: 引用元論文 156 件、この内訳の 2.1%スウェーデン: 引用元論文 133 件、この内訳の 1.8%
0%24.6%その他 29.5%

機関

分野

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology13.4%
  • Nursing2.4%
  • Environmental Science2.4%
  • Agricultural and Biological Sciences1.7%
  • Immunology and Microbiology1.3%
  • その他3.9%

トピック

  • Lipoproteins and Cardiovascular Health9.9%
  • Diabetes, Cardiovascular Risks, and Lipoproteins8.7%
  • Adipokines, Inflammation, and Metabolic Diseases4.8%
  • Lipid metabolism and disorders3.1%
  • Cardiovascular Disease and Adiposity2.2%
  • Adipose Tissue and Metabolism2%
  • その他69.3%

共著者

全論文

検索で開く
  1. Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

    著者: Jennifer G. Robinson, Michel Farnier, Michel Krempf, Jean Bergeron, Gérald Luc, Maurizio Averna, Erik S.G. Stroes, Gisle Langslet, Frederick J. Raal, Mahfouz El Shahawy, Michael J. Koren, Norman E. Lepor, Christelle Lorenzato, Robert Pordy, Umesh Chaudhari, John J.P. Kastelein - New England Journal of Medicine 2015 被引用: 2,289

  2. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

    著者: Joseph L. Witztum, Daniel Gaudet, Steven D. Freedman, Veronica Alexander, Andrés Digenio, Karren Williams, Qingqing Yang, Steven G. Hughes, Richard S. Geary, Marcello Arca, Erik S.G. Stroes, Jean Bergeron, Handrean Soran, Fernando Civeira, Linda Hemphill, Sotirios Tsimikas, Dirk Blom, Louis O’Dea, Éric Bruckert - New England Journal of Medicine 2019 被引用: 669

  3. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

    著者: Ioanna Gouni‐Berthold, Veronica J. Alexander, Qingqing Yang, Eunju Hurh, Elisabeth Steinhagen‐Thiessen, Patrick M. Moriarty, Stephen G. Hughes, Daniel Gaudet, Robert A. Hegele, Louis O’Dea, Erik S.G. Stroes, Sotirios Tsimikas, Joseph L. Witztum, Abhay Kumar Agarwal, Christie M. Ballantyne, Seth J. Baum, Jean Bergeron, Éric Bruckert, Richard K. Burdick, Manuel Castro-Cabezas, Mark Cervi, Clinton N. Corder, Robert Dufour, Cecil Murray Farrington, Gordon Francis, Lawrence Galitz, Steven Hamstead, Linda Hemphill, Cynthia Huffman, Basil Issa, Ulrich Julius, John P. Kane, Michel Krempf, Steven W. Martin, James J. Powell, Richard Shultzaberger, Craig Thompson, Letitia Thompson-Hargrave, Peter P. Tóth, Traci Turner, René Valéro, Bruno Vergès, Frank L.J. Visseren, Pankaj Vyas, Alberto R. Yataco - The Lancet Diabetes & Endocrinology 2021 被引用: 226

  4. Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial

    著者: Robert S. Rosenson, Daniel Gaudet, Christie M. Ballantyne, Seth J. Baum, Jean Bergeron, Erin E. Kershaw, Patrick M. Moriarty, Paolo Rubba, David C. Whitcomb, Poulabi Banerjee, Andrew Gewitz, Claudia Gonzaga‐Jauregui, Jennifer McGinniss, Manish P. Ponda, Robert Pordy, Jian Zhao, Daniel J. Rader - Nature Medicine 2023 被引用: 130

  5. Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk

    著者: Jean‐Pierre Després, Isabelle Lemieux, Jean Bergeron, Philippe Pîbarot, Patrick Mathieu, Éric Larose, Josep Rodés‐Cabau, Olivier F. Bertrand, Paul Poirier - Arteriosclerosis Thrombosis and Vascular Biology 2008 被引用: 1,581

  6. Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

    著者: Patrick M. Moriarty, Paul D. Thompson, Christopher P. Cannon, John R. Guyton, Jean Bergeron, Franklin J. Zieve, Éric Bruckert, Terry A. Jacobson, Stephen L. Kopecky, Marie T. Baccara‐Dinet, Yunling Du, Robert Pordy, Daniel A. Gipe - Journal of clinical lipidology 2015 被引用: 467

  7. Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia

    著者: Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh, Albert Wiegman, François Mach, Christopher E. Kurtz, Andrew Hamer, Ian Bridges, Andrea Bartuli, Jean Bergeron, T Szamosi, Saikat Santra, Claudia Stefanutti, Olivier Descamps, Susanne Greber‐Platzer, Ilse K. Luirink, John J.P. Kastelein, Daniel Gaudet - New England Journal of Medicine 2020 被引用: 190

  8. Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial

    著者: Frederick J. Raal, Nyda Fourie, Russell Scott, Dirk Blom, Matthys De Vries Basson, Meral Kayıkçıoğlu, Kate Caldwell, David Kallend, Evan A. Stein, LIBerate-HeFH Investigators, Traci Turner, Jean Bergeron, Artuela Çaku, Avishay Elis, Ronen Durst, Zafer Yalım, Meral Kayıkçıoğlu, Bahadır Kırılmaz, Ataç Çelik, Irfan Duzen, Abdurraham Oguzhan, İbrahim Başarıcı, Frederick J. Raal, Dirk Blom, M Abelson, Matthys M de V Basson, Lesley Burgess, Nyda Fourie, Eli Heggen, Emil Andreas Asprusten, Vimal Mehta, Raman Puri, Ashwani Mehta, Preeti Gupta, Milan Chag, Akshyaya Pradhan, Francisco Fuentes Jimenez, Fernando Civeira Murillo, Xavier Pinto Sala, Russell Scott - European Heart Journal 2023 被引用: 67

  9. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia

    著者: Robert A. Hegele, Amanda J. Berberich, Matthew R. Ban, Jian Wang, Andrés Digenio, Veronica J. Alexander, Laura D’Erasmo, Marcello Arca, Alan Jones, Éric Bruckert, Erik S.G. Stroes, Jean Bergeron, Fernando Civeira, Joseph L. Witztum, Daniel Gaudet - Journal of clinical lipidology 2018 被引用: 160

  10. Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Consensus Working Group Update (2016)

    著者: G.B. John Mancini, Steven K. Baker, Jean Bergeron, David Fitchett, Jiří Fröhlich, Jacques Genest, Milan Gupta, Robert A. Hegele, Dominic S. Ng, Glen J. Pearson, Janet Pope, A. Yashar Tashakkor - Canadian Journal of Cardiology 2016 被引用: 252

  11. Hypertriglyceridemic Waist

    著者: Isabelle Lemieux, Agnès Pascot, Charles Couillard, Benoı̂t Lamarche, André Tchernof, Natalie Alméras, Jean Bergeron, Daniel Gaudet, G Tremblay, Denis Prud’homme, André Nadeau, Jean‐Pierre Després - Circulation 2000 被引用: 934

  12. A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I

    著者: Eli M. Roth, Patrick M. Moriarty, Jean Bergeron, Gisle Langslet, Garen Manvelian, Jian Zhao, Marie T. Baccara‐Dinet, Daniel J. Rader - Atherosclerosis 2016 被引用: 124

  13. Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

    著者: Raúl D. Santos, Andrea Ruzza, G. Kees Hovingh, Claudia Stefanutti, François Mach, Olivier Descamps, Jean Bergeron, Bei Wang, Andrea Bartuli, Paola Sabrina Buonuomo, Susanne Greber‐Platzer, Ilse K. Luirink, Ajay Bhatia, Frederick J. Raal, John J.P. Kastelein, Albert Wiegman, Daniel Gaudet - The Lancet Diabetes & Endocrinology 2022 被引用: 48

  14. Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men

    著者: Isabelle Lemieux, Benoı̂t Lamarche, Charles Couillard, Agnès Pascot, Bernard Cantin, Jean Bergeron, Gilles R. Dagenais, Jean‐Pierre Després - Archives of Internal Medicine 2001 被引用: 489

  15. Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018

    著者: Liam R. Brunham, Isabelle L. Ruel, Sumayah Aljenedil, Jean‐Baptiste Rivière, Alexis Baass, Jack V. Tu, G.B. John Mancini, Paolo Raggi, Milan Gupta, Patrick Couture, Glen J. Pearson, Jean Bergeron, Gordon A. Francis, Brian W. McCrindle, Katherine M. Morrison, Julie St‐Pierre, Mélanie Henderson, Robert A. Hegele, Jacques Genest, Jeannette Goguen, Daniel Gaudet, Guillaume Paré, Jacques Romney, Thomas Ransom, Sophie Bernard, Pamela Katz, Tisha Joy, David Bewick, James M. Brophy - Canadian Journal of Cardiology 2018 被引用: 138

  16. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with β-quantification in a large population

    著者: André Tremblay, Hugo Morrissette, Jean-Marc Gagné, Jean Bergeron, Claude Gagné, Patrick Couture - Clinical Biochemistry 2004 被引用: 227

  17. Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial

    著者: Evan A. Stein, Dan Gipe, Jean Bergeron, Daniel Gaudet, Robert Weiss, Robert Dufour, Richard Wu, Robert Pordy - The Lancet 2012 被引用: 579

  18. Effects of Endurance Exercise Training on Plasma HDL Cholesterol Levels Depend on Levels of Triglycerides

    著者: Charles Couillard, Jean‐Pierre Després, Benoı̂t Lamarche, Jean Bergeron, Jacques Gagnon, Arthur S. Leon, D. C. Rao, James S. Skinner, Jack H. Wilmore, Claude Bouchard - Arteriosclerosis Thrombosis and Vascular Biology 2001 被引用: 332

  19. Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

    著者: Erik S.G. Stroes, John R. Guyton, Norman E. Lepor, Fernando Civeira, Daniel Gaudet, Gerald F. Watts, Marie T. Baccara‐Dinet, Guillaume Lecorps, Garen Manvelian, Michel Farnier, Karam Kostner, Sam J. Lehman, Olivier Descamps, Lien Gheyle, Chantal Mathieu, Jean Bergeron, Tom Elliott, Gabriel Girard, Arpeta Gupta, Gordon Hoag, Jens Dahlgaard Hove, Jørgen Jeppesen, J.H. Kjærulf, K. Klarlund, K.K. Thomsen, Dick C.G. Basart, Adriaan Kooy, Anho Liem, H. Swart, Roland P.T. Troquay, J Van Het Hof‐Wiersma, P. P. Viergever, Frank L.J. Visseren, Robert N. Doughty, Robert C. Scott, Carlos Calvo, José Luis Díaz-Díaz, Francisco Fuentes, Blas Gil Extremera, Carlos Rilova Jericó, Laia Matas Pericas, Juan Díaz García, D. Eric Bolster, Michael J. Koren, Mahfouz El Shahawy, Gil Vardi, D. Weinstein, K. Zuzarte, Henry N. Ginsberg, Jennifer G. Robinson, Daniel J. Rader, Christopher P. Cannon, Helen M. Colhoun, John J.P. Kastelein, Yong Huo, Anders Olsson, David D. Waters, Dominique Larrey, Robert S. Rosenson, P. Patriarca, Geert Molenberghs, Pierluigi Tricoci, Kenneth W. Mahaffey, Renato D. Lópes, Bimal R. Shah, Rajendra H. Mehta, Matthew T. Roe, Zubin J. Eapen, Luciana Armaganijan, Adriana Bertolami, Sergio Leonardi, Brad J. Kolls, J. Dedrick Jordan, Grégory Ducrocq, Étienne Puymirat, Robin Mathews - Journal of the American Heart Association 2016 被引用: 102

  20. Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomised, placebo-controlled trial

    著者: Patricia Lemieux, S. John Weisnagel, Annabelle Z. Caron, Anne‐Sophie Julien, Anne‐Sophie Morisset, Anne‐Marie Carreau, Jonathan Poirier, André Tchernof, Julie Robitaille, Jean Bergeron, André Marette, Marie‐Claude Vohl, Claudia Gagnon - European Journal of Endocrinology 2019 被引用: 99

  21. Real-World Insights Into Evolocumab Use in Patients With Hyperlipidemia: Canadian Analysis From the ZERBINI Study

    著者: Milan Gupta, G.B. John Mancini, Rajvi J. Wani, Vineeta Ahooja, Jean Bergeron, Priya Manjoo, A. Shekhar Pandey, Maureen Reiner, Johnny Beltran, Thiago Oliveira, Erin S. Mackinnon - CJC Open 2022 被引用: 38

  22. Race, Visceral Adipose Tissue, Plasma Lipids, and Lipoprotein Lipase Activity in Men and Women

    著者: Jean‐Pierre Després, Charles Couillard, Jacques Gagnon, Jean Bergeron, Arthur S. Leon, D. C. Rao, James S. Skinner, Jack H. Wilmore, Claude Bouchard - Arteriosclerosis Thrombosis and Vascular Biology 2000 被引用: 390

  23. Circulating Levels of Oxidative Stress Markers and Endothelial Adhesion Molecules in Men with Abdominal Obesity

    著者: Charles Couillard, Guillaume Ruel, W. Roodly Archer, Sonia Pomerleau, Jean Bergeron, Patrick Couture, Benoı̂t Lamarche, Nathalie Bergeron - The Journal of Clinical Endocrinology & Metabolism 2005 被引用: 199

  24. Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B

    著者: Allan D. Sniderman, André Tremblay, Jean Bergeron, Claude Gagné, Patrick Couture - Journal of clinical lipidology 2007 被引用: 89